Compare VNRX & PDC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VNRX | PDC |
|---|---|---|
| Founded | N/A | 2018 |
| Country | United States | Japan |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.2M | 24.2M |
| IPO Year | 2012 | 2022 |
| Metric | VNRX | PDC |
|---|---|---|
| Price | $0.18 | $3.12 |
| Analyst Decision | Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $13.62 | N/A |
| AVG Volume (30 Days) | ★ 1.9M | 27.7K |
| Earning Date | 11-12-2026 | 09-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 38.00 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,727,384.00 | N/A |
| Revenue This Year | $57.67 | N/A |
| Revenue Next Year | $240.52 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 40.04 | N/A |
| 52 Week Low | $0.13 | $2.42 |
| 52 Week High | $3.26 | $8.40 |
| Indicator | VNRX | PDC |
|---|---|---|
| Relative Strength Index (RSI) | 21.94 | 44.93 |
| Support Level | $0.14 | $2.64 |
| Resistance Level | $0.18 | $3.72 |
| Average True Range (ATR) | 0.02 | 0.37 |
| MACD | 0.01 | -0.03 |
| Stochastic Oscillator | 1.56 | 7.96 |
VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on diagnostics and monitoring.
Perpetuals.com Ltd is a financial technology company bridging traditional financial markets with blockchain-based infrastructure. The group operates regulated financial market infrastructure at the intersection of traditional finance and digital assets. Its B2B offerings include capital markets technology delivered as SaaS and institutional-grade custody through Crypto Vault. For consumers, it provides compliant retail trading and prediction market platforms. The group's operations across the USA, Europe, and Asia develop software solutions that enable regulated trading venues to operate with 24/7 self-clearing and blockchain-based settlement technology, empowering institutions to compete in the evolving landscape of digital finance.